NCLEX Review Guide: Laxatives & Stool Softeners

Bulk-Forming Laxatives

• Bulk-forming laxatives work by absorbing water in the intestine to form a viscous solution that promotes peristalsis and defecation. Examples include psyllium (Metamucil), methylcellulose (Citrucel), and polycarbophil (FiberCon).
• These agents are considered the safest for long-term use as they most closely replicate natural defecation processes and have minimal systemic effects.

Osmotic Laxatives

• Osmotic laxatives draw water into the intestinal lumen through osmosis, increasing intraluminal pressure and stimulating peristalsis. Common examples include polyethylene glycol (MiraLAX), magnesium hydroxide (Milk of Magnesia), magnesium citrate, and lactulose.
• Lactulose has a dual mechanism as it is also metabolized by colonic bacteria to produce organic acids that lower colonic pH and increase peristalsis.

Stimulant Laxatives

• Stimulant laxatives directly stimulate the enteric nervous system to increase intestinal motility and secretion. They include bisacodyl (Dulcolax), senna (Senokot), and cascara sagrada.
• These agents cause active secretion of electrolytes and water into the intestinal lumen and stimulate peristaltic contractions.

Stool Softeners

• Stool softeners (emollient laxatives) facilitate the mixing of fat and water in the stool to soften it. The primary example is docusate sodium (Colace) or docusate calcium (Surfak).
• These agents are surfactants that lower surface tension, allowing water to penetrate the stool more effectively.

Lubricant Laxatives

• Lubricant laxatives coat the stool and intestinal mucosa with a waterproof film, allowing for easier passage. The primary example is mineral oil.
• These agents prevent water absorption from the stool, keeping it soft and facilitating passage.

Routes of Administration

• Laxatives can be administered orally (tablets, capsules, powders, solutions) or rectally (suppositories, enemas). The route affects onset of action, with rectal administration generally providing faster relief.
• Suppositories (bisacodyl, glycerin) stimulate the rectal mucosa directly and typically work within 15-60 minutes. Enemas work through direct distention of the rectum and colon, usually producing results within 5-15 minutes.

Timing of Administration

• The timing of laxative administration is crucial for optimal effect and patient comfort. Bulk-forming and osmotic laxatives are typically taken with meals to ensure adequate fluid intake.
• Stimulant laxatives are often administered at bedtime to produce a bowel movement in the morning, aligning with the body's natural circadian rhythm for defecation.

Indications for Use

• Laxatives are primarily indicated for constipation, which is defined as infrequent bowel movements (typically fewer than three per week) or difficult passage of stool. They are also used for bowel preparation before diagnostic procedures or surgery.
• Specific populations with increased risk of constipation include the elderly, pregnant women, postpartum patients, post-surgical patients, and those taking constipating medications (opioids, anticholinergics, calcium channel blockers).

Contraindications & Precautions

• Laxatives are contraindicated in patients with suspected intestinal obstruction, acute surgical abdomen, undiagnosed abdominal pain, inflammatory bowel conditions (during acute flares), and fecal impaction (except for agents specifically used to treat it).
• Specific laxatives have unique contraindications: magnesium-containing laxatives in renal impairment; stimulant laxatives in inflammatory bowel disease; bulk-forming agents in intestinal narrowing or dysphagia.

Adverse Effects & Monitoring

• Common adverse effects of laxatives include abdominal cramping, flatulence, bloating, and diarrhea. Specific classes have unique side effects: bulk-forming agents may cause esophageal obstruction if not taken with adequate fluid; osmotic agents can cause electrolyte imbalances.
• Long-term use of stimulant laxatives can lead to dependency, cathartic colon (loss of normal colonic function), and electrolyte disturbances, particularly hypokalemia which may be dangerous in patients taking digoxin or certain antiarrhythmics.

Nursing Interventions

1. Perform a thorough assessment of bowel patterns, including frequency, consistency, and associated symptoms.
2. Evaluate current medication regimen for drugs that may cause constipation.
3. Implement and educate on non-pharmacological interventions first (adequate hydration, dietary fiber, regular exercise, scheduled toileting).
4. Administer the appropriate laxative based on the type of constipation and patient characteristics.
5. Monitor bowel movements and document effectiveness of the intervention.
6. Assess for adverse effects, particularly abdominal pain, electrolyte imbalances, and dehydration.
7. Provide education on proper administration, expected effects, and when to seek medical attention.

Common Pitfalls to Avoid

• Not considering contraindications: Always rule out intestinal obstruction, appendicitis, or undiagnosed abdominal pain before administering laxatives.
• Overlooking drug interactions: Laxatives can affect the absorption of other medications by decreasing transit time or binding to them (especially bulk-forming agents).
• Inadequate fluid intake: Failing to ensure adequate hydration, especially with bulk-forming agents, can worsen constipation or cause obstruction.
• Inappropriate laxative selection: Choosing a fast-acting stimulant when a gentler approach is needed, or using a slow-acting bulk-forming agent for acute constipation.

NCLEX Practice Strategies

• For questions about laxative selection, consider the patient's condition, desired onset of action, and contraindications to determine the most appropriate agent.
• When faced with questions about adverse effects, remember that electrolyte imbalances are most common with osmotic and stimulant laxatives, while mechanical obstruction is a risk with bulk-forming agents.
• For priority-setting questions, remember that assessment always comes before intervention - ensure the patient doesn't have symptoms of obstruction or acute abdomen before administering laxatives.

Quick Check

Self-Assessment Checklist

• I can classify the major types of laxatives and explain their mechanisms of action.
• I can identify appropriate indications for each class of laxative.
• I understand the contraindications and precautions for laxative use.
• I can explain the nursing considerations for administering different laxatives.
• I can identify potential adverse effects of laxatives and appropriate monitoring parameters.
• I understand the special considerations for laxative use in specific populations (elderly, pregnant, children).

Essential Concepts

• Laxatives are agents that promote defecation through various mechanisms, including increasing stool bulk, drawing water into the intestine, stimulating peristalsis, or softening stool consistency.
• The five main classes of laxatives are bulk-forming, osmotic, stimulant, stool softeners, and lubricant laxatives, each with distinct mechanisms, onset of action, and clinical applications.
• Selection of the appropriate laxative should be based on the cause of constipation, desired onset of action, patient characteristics, and potential contraindications or adverse effects.
• Non-pharmacological interventions (adequate hydration, dietary fiber, physical activity) should be the first-line approach to managing constipation before initiating laxative therapy.
• Long-term use of certain laxatives, particularly stimulant types, can lead to dependency, electrolyte imbalances, and altered bowel function, necessitating careful monitoring and patient education.